{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:59:26Z","timestamp":1777877966661,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Program Project of Jiangxi Provincial Health Commission","award":["202130051"],"award-info":[{"award-number":["202130051"]}]},{"name":"Jiangxi Provincial Health Commission project","award":["202610361"],"award-info":[{"award-number":["202610361"]}]},{"name":"Science and Technology Program Project of Jiangxi Provincial Administration of Traditional Chinese Medicine","award":["2020A0384"],"award-info":[{"award-number":["2020A0384"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04851-2","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:09:17Z","timestamp":1774278557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction and evaluation of a bladder cancer prognosis model based on super-enhancer-associated genes"],"prefix":"10.1007","volume":"17","author":[{"given":"Lieyu","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinchang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"4851_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.canep.2019.05.011","volume":"61","author":"X Liu","year":"2019","unstructured":"Liu X, Jiang J, Yu C, Wang Y, Sun Y, Tang J, et al. Secular trends in incidence and mortality of bladder cancer in China, 1990\u20132017: A joinpoint and age-period-cohort analysis. Cancer Epidemiol. 2019;61:95\u2013103.","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"4851_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4851_CR3","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4851_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskjot","year":"2023","unstructured":"Dyrskjot L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, et al. Bladder cancer. Nat Rev Dis Primers. 2023;9(1):58.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"4851_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","volume":"19","author":"JY Teoh","year":"2022","unstructured":"Teoh JY, Kamat AM, Black PC, Grivas P, Shariat SF, Babjuk M. Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective. Nat Rev Urol. 2022;19(5):280\u201394.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"4851_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, de Reynies A, Allory Y, Sjodahl G, Robertson AG, Seiler R, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol. 2020;77(4):420\u201333.","journal-title":"Eur Urol"},{"key":"4851_CR7","doi-asserted-by":"publisher","unstructured":"Dai H, Yu Z, Zhao Y et al. Integrating machine learning models with multi-omics analysis to decipher the prognostic significance of mitotic catastrophe heterogeneity in bladder cancer. Biol Direct. 2025;20(1):56. Published 2025 Apr 21. https:\/\/doi.org\/10.1186\/s13062-025-00650-x","DOI":"10.1186\/s13062-025-00650-x"},{"key":"4851_CR8","doi-asserted-by":"publisher","unstructured":"Ma C, Wang Z, Zhu X et al. Super enhancer-driven LINC01013 mediates hypoxia-induced mitochondrial dysfunction by HSPA9 to determine pulmonary arterial smooth muscle cell fate. Cell Mol Life Sci. 2026;83(1):57. Published 2026 Jan 6. https:\/\/doi.org\/10.1007\/s00018-025-06071-3","DOI":"10.1007\/s00018-025-06071-3"},{"issue":"6400","key":"4851_CR9","doi-asserted-by":"publisher","first-page":"eaar3958","DOI":"10.1126\/science.aar3958","volume":"361","author":"BR Sabari","year":"2018","unstructured":"Sabari BR, Dall\u2019Agnese A, Boija A, et al. Coactivator condensation at super-enhancers links phase separation and gene control. Science. 2018;361(6400):eaar3958. https:\/\/doi.org\/10.1126\/science.aar3958.","journal-title":"Science"},{"issue":"2","key":"4851_CR10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10555-023-10103-4","volume":"42","author":"M Bacabac","year":"2023","unstructured":"Bacabac M, Xu W. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets. Cancer Metastasis Rev. 2023;42(2):471\u201380.","journal-title":"Cancer Metastasis Rev"},{"key":"4851_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41698-020-0108-z","volume":"4","author":"F Tang","year":"2020","unstructured":"Tang F, Yang Z, Tan Y, Li Y. Super-enhancer function and its application in cancer targeted therapy. NPJ Precis Oncol. 2020;4:2.","journal-title":"NPJ Precis Oncol"},{"key":"4851_CR12","doi-asserted-by":"publisher","unstructured":"Dai H, Zhang X, Yin L et al. Integrating machine learning and multi-omics analysis to explore Treg-associated programmed cell death features in clear cell renal cell carcinoma. Cancer Cell Int. 2026;26(1):15. Published 2026 Jan 9. https:\/\/doi.org\/10.1186\/s12935-025-04133-x","DOI":"10.1186\/s12935-025-04133-x"},{"issue":"1","key":"4851_CR13","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1186\/s12885-023-11241-2","volume":"23","author":"Q Wu","year":"2023","unstructured":"Wu Q, Tao X, Luo Y, Zheng S, Lin N, Xie X. A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer. BMC Cancer. 2023;23(1):776.","journal-title":"BMC Cancer"},{"issue":"1","key":"4851_CR14","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s42003-023-04973-1","volume":"6","author":"Q Ma","year":"2023","unstructured":"Ma Q, Zhao M, Long B, Li H. Super-enhancer-associated gene CAPG promotes AML progression. Commun Biol. 2023;6(1):622.","journal-title":"Commun Biol"},{"issue":"9","key":"4851_CR15","doi-asserted-by":"publisher","first-page":"e0291088","DOI":"10.1371\/journal.pone.0291088","volume":"18","author":"Y Liu","year":"2023","unstructured":"Liu Y. Identification and comprehensive analysis of super-enhancer related genes involved in epithelial-to-mesenchymal transition in lung adenocarcinoma. PLoS ONE. 2023;18(9):e0291088.","journal-title":"PLoS ONE"},{"key":"4851_CR16","doi-asserted-by":"crossref","unstructured":"Liu S, Wang Z, Zhu R, Wang F, Cheng Y, Liu Y. Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2. J Vis Exp. 2021(175).","DOI":"10.3791\/62528"},{"issue":"1","key":"4851_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12885-020-06743-2","volume":"20","author":"X Li","year":"2020","unstructured":"Li X, Yu W, Liang C, Xu Y, Zhang M, Ding X, et al. INHBA is a prognostic predictor for patients with colon adenocarcinoma. BMC Cancer. 2020;20(1):305.","journal-title":"BMC Cancer"},{"issue":"1","key":"4851_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13008-025-00172-y","volume":"20","author":"H Dai","year":"2025","unstructured":"Dai H, Wang X, Wu Q, et al. Integrating genetic crosstalk between atherosclerosis and lung adenocarcinoma to advance precision diagnosis and treatment. Cell Div. 2025;20(1):27. https:\/\/doi.org\/10.1186\/s13008-025-00172-y. Published 2025 Nov 14.","journal-title":"Cell Div"},{"key":"4851_CR19","doi-asserted-by":"publisher","first-page":"554759","DOI":"10.3389\/fonc.2020.554759","volume":"10","author":"X Wu","year":"2020","unstructured":"Wu X, Sui Z, Zhang H, Wang Y, Yu Z. Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma. Front Oncol. 2020;10:554759.","journal-title":"Front Oncol"},{"key":"4851_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.gene.2019.01.001","volume":"692","author":"L Chen","year":"2019","unstructured":"Chen L, Lu D, Sun K, Xu Y, Hu P, Li X, et al. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Gene. 2019;692:119\u201325.","journal-title":"Gene"},{"issue":"1","key":"4851_CR21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s12885-022-09587-0","volume":"22","author":"K Dai","year":"2022","unstructured":"Dai K, Liu C, Guan G, Cai J, Wu L. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma. BMC Cancer. 2022;22(1):496.","journal-title":"BMC Cancer"},{"issue":"8","key":"4851_CR22","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364\u201370.","journal-title":"J Clin Oncol"},{"key":"4851_CR23","doi-asserted-by":"publisher","first-page":"692728","DOI":"10.3389\/fonc.2021.692728","volume":"11","author":"W Wang","year":"2021","unstructured":"Wang W, Liu J, Liu L. Development and Validation of a Prognostic Model for Predicting Overall Survival in Patients With Bladder Cancer: A SEER-Based Study. Front Oncol. 2021;11:692728.","journal-title":"Front Oncol"},{"issue":"2","key":"4851_CR24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/biom.12447","volume":"72","author":"S Dutta","year":"2016","unstructured":"Dutta S, Datta S. A rank-sum test for clustered data when the number of subjects in a group within a cluster is informative. Biometrics. 2016;72(2):432\u201340.","journal-title":"Biometrics"},{"key":"4851_CR25","doi-asserted-by":"publisher","first-page":"984158","DOI":"10.3389\/fgene.2022.984158","volume":"13","author":"W Wu","year":"2022","unstructured":"Wu W, Dong J, Lv Y, Chang D. Cuproptosis-Related genes in the prognosis of colorectal cancer and their correlation with the tumor microenvironment. Front Genet. 2022;13:984158.","journal-title":"Front Genet"},{"key":"4851_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-1-0716-1084-8_17","volume":"2239","author":"K Hu","year":"2021","unstructured":"Hu K. Become Competent in Generating RNA-Seq Heat Maps in One Day for Novices Without Prior R Experience. Methods Mol Biol. 2021;2239:269\u2013303.","journal-title":"Methods Mol Biol"},{"key":"4851_CR27","doi-asserted-by":"publisher","first-page":"8060477","DOI":"10.1155\/2021\/8060477","volume":"2021","author":"W Lin","year":"2021","unstructured":"Lin W, Wang Y, Chen Y, Wang Q, Gu Z, Zhu Y. Role of Calcium Signaling Pathway-Related Gene Regulatory Networks in Ischemic Stroke Based on Multiple WGCNA and Single-Cell Analysis. Oxid Med Cell Longev. 2021;2021:8060477.","journal-title":"Oxid Med Cell Longev"},{"key":"4851_CR28","doi-asserted-by":"publisher","unstructured":"Dai H, Zhao K, Zhao Y et al. Machine learning model in multi-omics perspective demystifies the prognostic significance of crotonylation heterogeneity in clear cell renal cell carcinoma. BMC Urol. 2025;25(1):229. Published 2025 Sep 15. https:\/\/doi.org\/10.1186\/s12894-025-01914-4","DOI":"10.1186\/s12894-025-01914-4"},{"issue":"S6","key":"4851_CR29","first-page":"e2021456","volume":"92","author":"A Arghittu","year":"2021","unstructured":"Arghittu A, Deiana G, Dettori M, Dempsey E, Masia MD, Plamieri A, et al. Web-based analysis on the role of Digital Media in Health Communication: the experience of VaccinarSinSardegna Website. Acta Biomed. 2021;92(S6):e2021456.","journal-title":"Acta Biomed"},{"key":"4851_CR30","doi-asserted-by":"publisher","first-page":"955441","DOI":"10.3389\/fimmu.2022.955441","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Zhang D, Cao Y, Zhang H, Li J, Xu J, et al. Screening of crosstalk and pyroptosis-related genes linking periodontitis and osteoporosis based on bioinformatics and machine learning. Front Immunol. 2022;13:955441.","journal-title":"Front Immunol"},{"key":"4851_CR31","doi-asserted-by":"publisher","first-page":"843408","DOI":"10.3389\/fimmu.2022.843408","volume":"13","author":"T Wang","year":"2022","unstructured":"Wang T, Dai L, Shen S, Yang Y, Yang M, Yang X, et al. Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm. Front Immunol. 2022;13:843408.","journal-title":"Front Immunol"},{"key":"4851_CR32","doi-asserted-by":"publisher","unstructured":"Dai H, Zhang X, Zhao Y et al. ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatment. Hereditas. 2025;162(1):42. Published 2025 Mar 19. https:\/\/doi.org\/10.1186\/s41065-025-00409-4","DOI":"10.1186\/s41065-025-00409-4"},{"issue":"4","key":"4851_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.trecan.2017.03.006","volume":"3","author":"S Sengupta","year":"2017","unstructured":"Sengupta S, George RE. Super-Enhancer-Driven Transcriptional Dependencies in Cancer. Trends Cancer. 2017;3(4):269\u201381.","journal-title":"Trends Cancer"},{"issue":"11","key":"4851_CR34","doi-asserted-by":"publisher","first-page":"9918","DOI":"10.18632\/aging.205906","volume":"16","author":"Y Tang","year":"2024","unstructured":"Tang Y, Sang S, Gao S, Xu W, Zhou H, Xia X. Mechanistic insights into super-enhancer-related genes as prognostic signatures in colon cancer. Aging. 2024;16(11):9918\u201332.","journal-title":"Aging"},{"key":"4851_CR35","doi-asserted-by":"publisher","first-page":"1043203","DOI":"10.3389\/fonc.2023.1043203","volume":"13","author":"X Wei","year":"2023","unstructured":"Wei X, Zhou Z, Long M, Lin Q, Qiu M, Chen P, et al. A novel signature constructed by super-enhancer-related genes for the prediction of prognosis in hepatocellular carcinoma and associated with immune infiltration. Front Oncol. 2023;13:1043203.","journal-title":"Front Oncol"},{"issue":"7","key":"4851_CR36","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s11912-023-01421-5","volume":"25","author":"G Elayat","year":"2023","unstructured":"Elayat G, Punev I, Selim A. An Overview of Angiogenesis in Bladder Cancer. Curr Oncol Rep. 2023;25(7):709\u201328.","journal-title":"Curr Oncol Rep"},{"key":"4851_CR37","doi-asserted-by":"crossref","unstructured":"Papadaki V, Asada K, Watson JK, Tamura T, Leung A, Hopkins J et al. Two Secreted Proteoglycans, Activators of Urothelial Cell-Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression. Cancers (Basel). 2020;12(11).","DOI":"10.3390\/cancers12113362"},{"key":"4851_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.exphem.2023.07.001","volume":"125\u2013126","author":"Z Sun","year":"2023","unstructured":"Sun Z, Lin D, Shen Y, Ma K, Wang B, Liu H, et al. Critical role of MXRA7 in differentiation blockade in human acute promyelocytic leukemia cells. Exp Hematol. 2023;125\u2013126:45\u201354.","journal-title":"Exp Hematol"},{"key":"4851_CR39","doi-asserted-by":"publisher","first-page":"1618527","DOI":"10.1155\/2020\/1618527","volume":"2020","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ye Q, He J, Chen P, Wan J, Li J, et al. Recurrence-Associated Multi-RNA Signature to Predict Disease-Free Survival for Ovarian Cancer Patients. Biomed Res Int. 2020;2020:1618527.","journal-title":"Biomed Res Int"},{"issue":"2","key":"4851_CR40","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s10120-020-01128-7","volume":"24","author":"Y Pan","year":"2021","unstructured":"Pan Y, Wang X, He Y, Lin S, Zhu M, Li Y, et al. Tumor suppressor ATP4B serve as a promising biomarker for worsening of gastric atrophy and poor differentiation. Gastric Cancer. 2021;24(2):314\u201326.","journal-title":"Gastric Cancer"},{"key":"4851_CR41","doi-asserted-by":"crossref","unstructured":"Patwardhan MV, Mahendran R. The Bladder Tumor Microenvironment Components That Modulate the Tumor and Impact Therapy. Int J Mol Sci. 2023;24(15).","DOI":"10.3390\/ijms241512311"},{"issue":"7","key":"4851_CR42","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","volume":"181","author":"DY Oh","year":"2020","unstructured":"Oh DY, Kwek SS, Raju SS, Li T, McCarthy E, Chow E, et al. Intratumoral CD4(+) T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer. Cell. 2020;181(7):1612\u2013e2513.","journal-title":"Cell"},{"issue":"4","key":"4851_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","volume":"22","author":"M Philip","year":"2022","unstructured":"Philip M, Schietinger A. CD8(+) T cell differentiation and dysfunction in cancer. Nat Rev Immunol. 2022;22(4):209\u201323.","journal-title":"Nat Rev Immunol"},{"key":"4851_CR44","doi-asserted-by":"publisher","first-page":"105880","DOI":"10.1016\/j.intimp.2019.105880","volume":"76","author":"L Sharifi","year":"2019","unstructured":"Sharifi L, Nowroozi MR, Amini E, Arami MK, Ayati M, Mohsenzadegan M. A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting. Int Immunopharmacol. 2019;76:105880.","journal-title":"Int Immunopharmacol"},{"key":"4851_CR45","doi-asserted-by":"publisher","first-page":"963877","DOI":"10.3389\/fimmu.2022.963877","volume":"13","author":"S Pan","year":"2022","unstructured":"Pan S, Li S, Zhan Y, Chen X, Sun M, Liu X, et al. Immune status for monitoring and treatment of bladder cancer. Front Immunol. 2022;13:963877.","journal-title":"Front Immunol"},{"issue":"1","key":"4851_CR46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12967-024-05186-8","volume":"22","author":"K Zheng","year":"2024","unstructured":"Zheng K, Hai Y, Chen H, Zhang Y, Hu X, Ni K. Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model. J Transl Med. 2024;22(1):365.","journal-title":"J Transl Med"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04851-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04851-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04851-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:07:31Z","timestamp":1777590451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04851-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4851"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04851-2","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study and its protocols were approved by the Biomedical Research Ethics Committee of the Second Affiliated Hospital of Nanchang University and the Ethics Committee of Jiangxi Provincial People\u2019s Hospital. The study utilized human bladder cancer tissue samples collected from patients undergoing radical cystectomy at these two medical centers. Written informed consent was obtained from all participating patients after they were fully informed about the study\u2019s purpose, procedures, potential risks, and benefits. All patient data and samples were anonymized and handled in strict accordance with the ethical standards of the institutional review boards and with the principles of the Declaration of Helsinki. All patients were informed and agreed to participate in the study. All experiments were conducted in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"674"}}